Table 3.
Tumor size and axillary lymph node involvement in the BRCA1 and BRCA2 groups compared to triple-negative and non-triple-negative breast cancer in the registry group

OR=odds ratio of positivity of axillary lymph node involvement; Registry=patients of registry data; Non-TNT=non-triple-negative tumor; TNT=triple-negative tumor.